High glucose increases LPS-induced DC apoptosis through modulation of ERK1/2, AKT and Bax/Bcl-2
© Feng et al.; licensee BioMed Central Ltd. 2014
Received: 27 December 2013
Accepted: 14 May 2014
Published: 28 May 2014
This study investigates the effect of glucose on the LPS-induced apoptosis of dendritic cells in the intestinal tract of mice and the dendritic cell line DC2.4.
Flow cytometry was used to detect dendritic cell apoptosis both in vivo and in vitro. Hoechst 33258 staining was used to detect the morphological changes characteristic of apoptotic nuclei. Expression of apoptosis related proteins was investigated by western blot analysis and immunohistochemistry.
Pretreatment with a high concentration of glucose increased apoptosis of LPS-treated dendritic cells both in vivo and in vitro at 24 h. No effect was evident at the earlier time points of 15 min and 6 h in vitro. Furthermore, at 24 hours the expression of the survival proteins AKT, ERK and Bcl-2 was decreased, while the expression of the proapoptotic protein Bax was increased. AKT, ERK, Bcl-2 and Bax were mainly located in the cytoplasm by immunohistochemistry.
These results suggest that high glucose concentrations might prime dendritic cells for apoptosis induced by LPS in the intestinal tract through upregulating the expression of Bax and downregulating the expression of AKT, ERK and Bcl-2. Therefore, this study may give clues to understanding the immunological mechanism behind gastrointestinal complications in diabetes mellitus.
KeywordsDendritic cell Apoptosis Diabetes mellitus Glucose Gastrointestinal complications diabetes
There were approximately 285 million adults with diabetes worldwide in 2010, and the number has continued to increase . Diabetes can lead to premature death and has various complications associated with it including blindness, peripheral neuropathy, renal disease and cardiovascular diseases. The complications of diabetes mellitus are accelerated in people who also have poorly controlled blood sugar levels. Other risk factors for complications include smoking, elevated cholesterol levels, obesity, high blood pressure and lack of regular exercise . It has also been reported that high glucose levels induce immune cell apoptosis . Raab et al. additionally showed that high energy substrates in the diet increased apoptosis in the intestinal epithelium .
The immune system is pivotal in mediating interactions between the host and the microbiota that shape the intestinal environment [5, 6]. Furthermore, dendritic cells (DCs) are pivotal in tolerance induction and direct the differentiation of T cells in the intestine. Therefore, DC apoptosis will result in immunosuppression, promote regulatory T cell (Treg) generation and induce functional impairment of remaining DCs [7, 8]. Additionally, the gastrointestinal tract is continuously exposed to foreign antigens including invading bacteria and viruses, food antigens and also potentially altered-self antigens such as tumor antigens. Infection with certain bacteria and other pathogens can induce DC apoptosis, which will result in the dysregulation of the immune balance in the gastrointestinal tract . Thus, deeper understanding of the mechanism regulating intestinal DC apoptosis is needed.
It has been shown that PI3K (phosphatidylinositol-3-kinase)/AKT and MEK (MAP/ERK kinase)/ERK signaling is involved in the regulation of bone marrow-derived DC (BMDC) apoptosis, as inhibiting both PI3K and MEK resulted in 70% of the DCs undergoing apoptosis . Furthermore, AKT (also known as protein kinase B, PKB) and ERK (Extracellular signal-regulated protein kinases) are known regulators of DC cell survival . Additionally, it is also known Bax (Bcl-2 Associated X Protein) and Bcl-2 (B cell lymphoma/lewkmia-2) play a central role in regulating apoptosis . Increased expression of Bcl-2 and decreased expression of Bax promotes cell survival by inhibiting apoptosis .
As far as we know, there are no reports on the effect of high glucose concentrations on DC apoptosis in the mouse intestine. We hypothesized that high concentrations of glucose might accelerate LPS (Lipopolysaccharides) induced DC apoptosis in the mouse intestine through alteration of the activation of ERK, AKT, Bax and Bcl-2. We found that high glucose did indeed increase LPS-induced DC apoptosis. This effect was mediated through inhibition of AKT and ERK phosphorylation, increased Bax expression and decreased Bcl-2 expression. This study may give clues to understanding the mechanism behind the immunological changes present in the gut in diabetes mellitus.
Male BALB/c mice, 10 weeks old, were purchased from the Animal Center at Shandong University. All experimental procedures were approved by and performed according to the guidelines of the animal ethics committee of the Shandong University School of Medicine. In brief, mice were injected intraperitoneally with streptozotocin (STZ, 60 μg/g) once a day for 5 days to induce diabetes [14, 15]. Control mice were injected with PBS (Phosphate buffer saline). Seven days after the final injection, blood glucose levels were examined by glucometer (UltraVue, Johnson & Johnson, New Brunswick, NJ, USA). Mice with blood glucose levels greater than 300 mg/dl were considered diabetic. Diabetic mice were given LPS (1 mg in 500 μL PBS) orally once to induce inflammation on the 19th day after the first streptozotocin injection, while control mice were treated with the same volume of PBS. 24 hours later mice were killed and intestines dissected and digested with collagenase. Immune cells were isolated by layering on a Percoll gradient, then DCs were further purified using CD11c magnetic beads (130-052-001, Miltenyi Biotec Inc, Bergisch Gladbach, Germany) [16, 17]. Finally the DCs were collected, stained and analyzed by flow cytometry.
Dendritic cells (DC2.4 cell line) were cultured on collagen coated dishes in complete medium containing RPMI-1640, 10% fetal bovine serum, 1 × 104 units/ml penicillin and 10 mg/ml streptomycin. Cells were passaged using standard cell culture techniques. Culture dishes were placed in an incubator equilibrated with 5% CO2 at 37°C. The medium was refreshed at intervals of 3 days. To maintain uniform condition, the cells in passages 20 to 30 were used for experiments.
DC2.4 cells were treated with a high dose of glucose (25 mmol/L) for 48 h. Then LPS (100 μg/ml) was added to detect whether the glucose concentration could affect DC apoptosis. After 24 h LPS treatment (cells grown to approximately 80% confluence), the cells were harvested for both western blot analysis and flow cytometry.
Analysis of apoptosis by flow cytometry
Apoptosis of dendritic cells was determined using an Annexin-V and PI apoptosis kit (BU-ap0102, Life Technologies, Carlsbad, CA, USA). After washing twice with PBS, cells were re-suspended in binding buffer and incubated with Annexin-V and PI for 15 min. At least 5000 cells were counted per sample. Apoptotic cells appeared as Annexin-V positive and PI negative.
Analysis of apoptosis by Hoechst 33258 staining
Hoechst 33258 staining (B33258, Sigma, St Loius, MO, USA) was used to visualize the morphological changes in apoptotic cell nuclei. After being washed with PBS and fixed with 4% paraformaldehyde for 30 min, 0.5 μg/ml Hoechst 33258 was added to the wells and incubated for 5 min. Then cell nuclei were analyzed by fluorescence microscopy. Apoptotic cells were characterized by chromatin condensation and multiple chromatin fragments.
Cells were collected and washed three times with PBS before lysis in lysis buffer (MK163780, ThermoFisher Scientific Inc, Waltham, MA, USA). The protein concentration of the lysates was determined according to the BCA method using the Protein Quantitative Analysis kit (2812 k; CWBIO, CoWin Biotech Co. Ltd., Beijing, China). For electrophoresis, 100 μg of protein was loaded into the wells of a 10% SDS polyacrylamide gel. After separation, proteins were transferred to nitrocellulose membranes, blocked for 3 h at room temperature in blocking buffer (5% nonfat dry milk, Tween-Tris-buffered saline), washed in PBS 3 times and incubated with primary antibody of ABCAM (Rabbit polyclonal to ERK, ab16869, 1: 1:5000; Rabbit polyclonal to AKT, ab66138, 0.15 μg/ml; Rabbit polyclonal to Bax, ab7977, 1:1000; Rabbit polyclonal to Bcl-2, ab18210, 1 μg/ml) and Actin (sc-1616, 1:200, SANTA CRUZ BIOTECHNOLOGY) overnight at 4°C with gentle agitation. Next day after washing three times in PBS, the nitrocellulose membranes were blotted for 1 h at room temperature with secondary antibodies (ab136817, 1:5000, abcam). Finally, immunolabeled protein bands were detected using the ECL(Electro-Chemi-Luminescence) method (Immobilon™ Western, Millipore Corporation, Billerica, MA, USA) and quantified using an Alpha Imager 2200 (ProteinSimple, Santa Clara, CA, USA).
DC2.4 cells were treated as described above. After fixing in 4% paraformaldehyde for 15 min and washing with PBS, cells were permeabilized with 0.1% triton X-100 for 15 min. 3% hydrogen peroxide was used to block endogenous peroxidases. After washing in PBS and blocking in 10% goat serum, cells were incubated with primary antibody of ABCAM (Rabbit polyclonal to ERK, ab16869, 1:1000; Rabbit polyclonal to AKT, ab66138, 1 μg/ml; Rabbit polyclonal to Bax, ab7977, 1 μg/ml; Rabbit polyclonal to Bcl-2, ab18210, 5 μg/ml) and Actin (sc-1616, 1:250, SANTA CRUZ BIOTECHNOLOGY) overnight in a humidified chamber at 4°C. The next day, the cells were washed before being incubated with secondary antibody (SP rabbit HRP kit, CW2035, CWBIO) for 30 min at room temperature. After washing, positive immunostaining was revealed by the DAB(3,3’-diaminobenzidine) method (D8001, Sigma). PBS was used as a negative control for the primary antibodies and Actin was used as a positive control.
Data were analyzed with SigmaStat 3.5 software (SYSTAT Software, San Jose, CA, USA). One-way ANOVA analysis was followed by Dunnett’s test to analyze the differences among the groups. Data are presented as the mean ± SE of at least four independent experiments. P < 0.05 was considered a statistically significant difference.
Effects of glucose on LPS-treated dendritic cell apoptosis
Apoptosis related protein expression in dendritic cells
Location of apoptosis related proteins in dendritic cells
The immunoreactivity for the apoptosis related proteins (AKT, ERK, Bax, Bcl-2) were mainly located in the cytoplasm (Figure 3B). The negative control showed no background staining. Glucose administration decreased the number of positive cells for the antiapoptotic proteins AKT, ERK and Bcl-2 and also reduced the intensity of immunoreactivity of the labeled cells. In comparison, both the number and intensity of the Bax immunoreactive cells was increased.
The present study demonstrates that LPS-treated dendritic cells in the intestine of diabetic mice undergo increased apoptosis compared with normal mice. A similar effect was observed in the DC2.4 cell line in vitro. High glucose concentration increased the level of apoptosis of LPS-treated DCs via alterations in the AKT, ERK, Bax and Bcl-2 pathways. AKT, ERK Bax and Bcl-2 were mainly located in the cytoplasm of DCs.
LPS, the prototypical endotoxin, is the major component of the outer membrane of Gram-negative bacteria and through TLR4 can trigger both proapoptotic and antiapoptotic pathways . LPS can induce PBMC-derived DC apoptosis [19, 20], although other studies found no signs of apoptosis in LPS-treated DCs [21, 22]. The Enterobacteriaceae are a large, heterogeneous group of gram-negative bacilli whose natural habitat is the intestinal tract of humans and animals. These bacteria will cause disease when the immune balance is disrupted. Therefore we used LPS to mimic the presence of bacteria in the intestine to explore if high glucose can affect DC survival in the inflamed intestine. We found that LPS could elevate intestinal DC apoptosis. Furthermore, LPS could also increase DC2.4 apoptosis in a dose-dependent fashion (data not shown).
AKT and ERK proteins are known regulators of cell survival. AKT, a serine/threonine-specific protein kinase, plays as a central role in the signaling pathways regulating metabolism and cellular transformation. AKT can regulate cell growth and apoptosis by activating a series of downstream signaling molecules . It has been shown that DC maturation and antiapoptotic responses are associated with activation of AKT signaling. Blocking AKT signaling impairs DC maturation and induces apoptosis . ERK is an important mediator of BMDC activation . The Raf/MEK/ERK signaling pathway acts as an important element in DC generation and differentiation . In the present study, we found that LPS decreased the phosphorylation of AKT and ERK1/2 in DCs at 24 h. If the cells were pretreated with high glucose, there was a greater decrease in the phosphorylation of these survival factors.
The Bax/Bcl-2 family of proteins highlights the complexity of cellular biology. Bcl-2, an anti-apoptotic protein, is known to be a negative regulator of apoptosis which can prevent cytochrome c release from mitochondria and protect DNA from fragmentation. In cell culture, transfecting Bcl-2 into U937 cells protected the cells from apoptosis induced by various insults . Conversely Bax, a pro-apoptotic member of the Bax/Bcl-2 family, may be a key factor promoting cytochrome c release. The ratio of Bax to Bcl-2 is therefore a crucial determinant of apoptosis in the cell. In the present study, it was demonstrated that LPS increased the expression of Bax protein and decreased the expression of Bcl-2 protein in DCs at 24 h. If the cells were pretreated with high glucose, the ratio of Bax/Bcl-2 was further increased.
Taken together, our results showed that high glucose levels present in diabetic mice could increase the LPS-induced apoptosis of DCs in the inflamed intestine. Apoptosis related proteins such as AKT, ERK, Bax and Bcl-2 regulated LPS-induced apoptosis in DCs. Specifically, high glucose concentrations increased LPS-induced apoptosis in DCs by enhancing the down-regulation of AKT and ERK phosphorylation and the up-regulation of the Bax/Bcl-2 ratio. These results contribute to a greater understanding of the mechanism behind the immunological changes in the gastrointestinal tract of patients with diabetes mellitus.
Serine/threonine protein kinase/known as Protein Kinase B
Extracellular signal-regulated protein kinases
Bcl-2 Associated X Protein
B cell lymphoma/lewkmia-2.
This project was supported by the Natural Scientific Foundation of China (No. 31100836 and No. 81000731) and Excellent Young and Middle-aged Scientists of Shandong Province (BS2012YY024).
- Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G: Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010, 87 (3): 293-301. 10.1016/j.diabres.2010.01.026.View ArticlePubMed
- Winer N, Sowers JR: Epidemiology of diabetes. J Clin Pharmacol. 2004, 44 (4): 397-405. 10.1177/0091270004263017.View ArticlePubMed
- Otton R, Soriano FG, Verlengia R, Curi R: Diabetes induces apoptosis in lymphocytes. J Endocrinol. 2004, 182 (1): 145-156. 10.1677/joe.0.1820145.View ArticlePubMed
- Noda T, Iwakiri R, Fujimoto K, Yoshida T, Utsumi H, Sakata H, Hisatomi A, Aw TY: Suppression of apoptosis is responsible for increased thickness of intestinal mucosa in streptozotocin-induced diabetic rats. Metabolism. 2001, 50 (3): 259-264. 10.1053/meta.2001.21030.View ArticlePubMed
- Izcue A, Coombes JL, Powrie F: Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol. 2009, 27: 313-338. 10.1146/annurev.immunol.021908.132657.View ArticlePubMed
- Linton L, Karlsson M, Grundstrom J, Hjalmarsson E, Lindberg A, Lindh E, Glise H, Befrits R, Janczewska I, Karlen P, Winqvist O, Eberhardson M: HLA-DR(hi) and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD. Clin Transl Gastroenterol. 2012, 3: e29-10.1038/ctg.2012.23.PubMed CentralView ArticlePubMed
- Kushwah R, Hu J: Dendritic cell apoptosis: regulation of tolerance versus immunity. J Immunol. 2010, 185 (2): 795-802. 10.4049/jimmunol.1000325.View ArticlePubMed
- Ng SC, Benjamin JL, McCarthy NE, Hedin CR, Koutsoumpas A, Plamondon S, Price CL, Hart AL, Kamm MA, Forbes A, Knight SC, Lindsay JO, Whelan K, Stagg AJ: Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease. Inflamm Bowel Dis. 2011, 17 (10): 2027-2037. 10.1002/ibd.21590.View ArticlePubMed
- Arranz E, Pena AS, Bernardo D: Mediators of inflammation and immune responses in the human gastrointestinal tract. Mediators Inflamm. 2013, 865638-
- Xie J, Qian J, Yang J, Wang S, Freeman ME, Yi Q: Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells. Exp Hematol. 2005, 33 (5): 564-572. 10.1016/j.exphem.2005.03.001.View ArticlePubMed
- Schafer M, Koppe F, Stenger B, Brochhausen C, Schmidt A, Steinritz D, Thiermann H, Kirkpatrick CJ, Pohl C: Influence of organophosphate poisoning on human dendritic cells. Chem Biol Interact. 2013, 206 (3): 472-478. 10.1016/j.cbi.2013.08.011.View ArticlePubMed
- Nogueira CV, Lindsten T, Jamieson AM, Case CL, Shin S, Thompson CB, Roy CR: Rapid pathogen-induced apoptosis: a mechanism used by dendritic cells to limit intracellular replication of Legionella pneumophila. PLoS Pathog. 2009, 5 (6): e1000478-10.1371/journal.ppat.1000478.PubMed CentralView ArticlePubMed
- Chung J, Yoon YO, Lee JS, Ha TK, Ryu SM, Kim KH, Jeong MH, Yoon TR, Kim HK: Inulin induces dendritic cells apoptosis through the caspase-dependent pathway and mitochondrial dysfunction. Biol Pharm Bull. 2011, 34 (4): 495-500. 10.1248/bpb.34.495.View ArticlePubMed
- Chen WB, Gao L, Weiland M, Zhao J, Liu M, Zhou L, Mi QS: Deletion of miRNAs in bone marrow prevents streptozotocin-induced murine autoimmune diabetes but deletion of miR-155 does not. Cell Cycle. 12 (7): 1151-1152.
- Motyl K, McCabe LR: Streptozotocin, type I diabetes severity and bone. Biol Proced Online. 2009, 11: 296-315. 10.1007/s12575-009-9000-5.PubMed CentralView ArticlePubMed
- Chirdo FG, Millington OR, Beacock-Sharp H, Mowat AM: Immunomodulatory dendritic cells in intestinal lamina propria. Eur J Immunol. 2005, 35 (6): 1831-1840. 10.1002/eji.200425882.View ArticlePubMed
- Geem D, Medina-Contreras O, Kim W, Huang CS, Denning TL: Isolation and characterization of dendritic cells and macrophages from the mouse intestine. J Vis Exp. e4040-63
- Lombardo E, Alvarez-Barrientos A, Maroto B, Bosca L, Knaus UG: TLR4-mediated survival of macrophages is MyD88 dependent and requires TNF-alpha autocrine signalling. J Immunol. 2007, 178 (6): 3731-3739. 10.4049/jimmunol.178.6.3731.View ArticlePubMed
- Handley ME, Thakker M, Pollara G, Chain BM, Katz DR: JNK activation limits dendritic cell maturation in response to reactive oxygen species by the induction of apoptosis. Free Radic Biol Med. 2005, 38 (12): 1637-1652. 10.1016/j.freeradbiomed.2005.02.022.View ArticlePubMed
- Yen JH, Ganea D: Interferon beta induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation. Blood. 2009, 114 (7): 1344-1354. 10.1182/blood-2008-12-196592.PubMed CentralView ArticlePubMed
- Nakaya K, Nabata Y, Ichiyanagi T, An WW: Stimulation of dendritic cell maturation and induction of apoptosis in leukemia cells by a heat-stable extract from azuki bean (Vigna angularis), a promising immunopotentiating food and dietary supplement for cancer prevention. Asian Pac J Cancer Prev. 2012, 13 (2): 607-611. 10.7314/APJCP.2012.13.2.607.View ArticlePubMed
- Zhang H, Jiao Q, Gong Q, Zhang Y, Zhang W, Hu Z: Baicalin induced dendritic cell apoptosis in vitro. Frontiers in pharmacology. 2011, 2: 15-PubMed CentralView ArticlePubMed
- Zhang Y, Wang X, Yang H, Liu H, Lu Y, Han L, Liu G: Kinase AKT controls innate immune cell development and function. Immunology. 2013, 140 (2): 143-152. 10.1111/imm.12123.PubMed CentralView ArticlePubMed
- Stefanidou M, Ramos I, Mas Casullo V, Trepanier JB, Rosenbaum S, Fernandez-Sesma A, Herold BC: Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy. J Virol. 87 (3): 1443-1453.
- Srivastava RM, Varalakshmi C, Khar A: The ischemia-responsive protein 94 (Irp94) activates dendritic cells through NK cell receptor protein-2/NK group 2 member D (NKR-P2/NKG2D) leading to their maturation. J Immunol. 2008, 180 (2): 1117-1130. 10.4049/jimmunol.180.2.1117.View ArticlePubMed
- Teicher BA: Molecular targets and cancer therapeutics: discovery, development and clinical validation. Drug Resist Updat. 2000, 3 (2): 67-73. 10.1054/drup.2000.0123.View ArticlePubMed
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/14/98/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.